Related content

Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia

By  

Chemotherapy, Vol. 58, Iss. 4, 2012-11 ,pp. : 308-312

Karger

Access to resources Recommend Favorite

Therapeutic Drug Monitoring and Clinical Toxicology‐Opportunities Not to be Missed

By  

The Australian Journal of Hospital Pharmacy, Vol. 29, Iss. 2, 1999-04 ,pp. : 82-83

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications

By Krasowski Matthew D.  

Pharmaceuticals, Vol. 3, Iss. 6, 2010-06 ,pp. : 1909-1935

MDPI

Access to resources Recommend Favorite

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients in the Chronic Phase

By  

Pharmacology, Vol. 87, Iss. 5-6, 2011-04 ,pp. : 241-248

Karger

Access to resources Recommend Favorite

In Vivo and in Vitro Study on Drug-Drug Interaction of Lovastatin and Berberine from Pharmacokinetic and HepG2 Cell Metabolism Studies

By Cui Hanming   Wang Jialong   Zhang Qiuyan   Dang Mengmeng   Liu Hui   Dong Yu   Zhang Lu   Yang Fang   Wu Jianhua   Tong Xiaolin  

Molecules, Vol. 21, Iss. 4, 2016-04 ,pp. : 464-464

MDPI

Access to resources Recommend Favorite